Empagliflozin alleviates atherosclerotic calcification by inhibiting osteogenic differentiation of vascular smooth muscle cells

• المؤلفون الرئيسيون: Junping Li (مؤلف), Changping Li (مؤلف), Zhaoqi Huang (مؤلف), Chunling Huang (مؤلف), Juanzhang Liu (مؤلف), Tao Wu (مؤلف), Shuwan Xu (مؤلف), Peibiao Mai (مؤلف), Dengfeng Geng (مؤلف), Shuxian Zhou (مؤلف), Kun Zhang (مؤلف), Zhaoyu Liu (مؤلف)
• التنسيق: كتاب
• منشور في: Frontiers Media S.A., 2023-11-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

SGLT-2 inhibitors, such as empagliflozin, have been shown to reduce the occurrence of cardiovascular events and delay the progression of atherosclerosis. However, its role in atherosclerotic calcification remains unclear. In this research, ApoE−/− mice were fed with western diet and empagliflozin wa...